Breyer Capital
Austin, Texasbreyercapital.com
Overview
Breyer Capital is a premier venture capital and private equity investor focused on catalyzing high-impact entrepreneurs. Founded by Jim Breyer in 2006, Breyer Capital makes long-term, idea-driven strategic investments in artificial intelligence, healthcare, life sciences, enterprise, consumer, and financial technologies. The firm prides itself on maintaining an openness to experimentation that can lead to long-term breakthrough performance and partnering with founders and teams who are passionate about building transformative companies anchored in technology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Catena Labs | May 2026 | Series A | Co-investor |
| ParcelBio | May 2026 | Seed | Lead |
| SiFi | Feb 2026 | Series A | Co-investor |
| OpenEvidence | Jan 2026 | Series D | Co-investor |
| Soley Therapeutics | Jan 2026 | Series C | Co-investor |
Key People
Daniel Breyer
Partner
Ted Breyer
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.